Pulling SEC filings + quote and writing the call…

HEALTHY CHOICE WELLNESS CORP.
Next earnings Aug 12, 2026 · consensus $-0.04 EPS, $22.7M rev
Going-concern doubt, negative working capital and 115% dilution make this sub-$5M organic-food micro-cap uninvestable despite a 0.1x P/S.
Revenue $78.2M · FY2025
HCWC is a 19-store natural/organic grocery chain spun out of HCMC in September 2024, and the headline 12.7% revenue growth to $78.2M is almost entirely bought, not earned: management states the GreenAcres acquisition contributed ~$7.8M of the $8.8M increase, leaving just $1.0M of same-store sales growth. Beneath that, the business still does not make money — operating income was -$2.48M (worsening 39.8% YoY as SG&A rose $4.1M) and the company posted a -$3.94M net loss. Losses are narrowing (-$9.93M → -$4.51M → -$3.94M) and the 39.2% gross margin is genuinely strong for grocery, but three years into existence this is a structurally unprofitable retailer carrying standalone public-company costs.
The balance sheet is where the thesis breaks. MD&A explicitly flags 'net losses and negative working capital' and says cost-reduction initiatives and a 'committed equity financing' are 'critical to continuing as a going concern.' The numbers confirm it: $3.02M of cash against $12.7M current liabilities, current assets of only $9.98M (negative working capital of ~$2.7M), liabilities/equity of 3.59x, and $2.20M of debt now current. The rescue plan is equity issuance — and shares already ballooned 115.3% in a single year, so existing holders should expect further heavy dilution at a $0.21 price where the entire company is worth $4.71M.
Is HCWC a buy? The one-page verdict, explained →
AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue | $55.7M | $69.4M | $78.2M |
| Gross profit | $20.3M | $27.1M | $30.7M |
| Operating income | -$10.5M | -$1.78M | -$2.48M |
| Net income | -$9.93M | -$4.51M | -$3.94M |
| Diluted EPS | -$1.08 | -$0.48 | -$0.24 |
| Net margin | -17.8% | -6.5% | -5.0% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Entered new material definitive agreement (financing/supply); terms filed as exhibits
Signed another material agreement; details in exhibits, no financial impact quantified
Q1'26 results amid ongoing losses and going-concern reliance on equity financing
FY25 sales +12.7% to $78.2M, loss narrowed, but going-concern doubt + material weakness
New agreement plus unregistered stock sale — added dilution to fund operations
Reported annual-meeting voting results; routine governance, no operational change
Annual proxy — director elections and routine approvals, no business change
Financing deal with unregistered shares, charter change and modified shareholder rights
Filed shelf registration enabling future securities sales — dilution overhang
Sources: SEC EDGAR (CIK 0001948864, latest 10-Q filed 2026-05-15) · EODHD · Proprietary analysis · as of 7/4/2026, 9:57:46 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 5:57 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-06-02 | Santi Christopher President | Award | 815K | |
| 2026-06-02 | Ollet John Chief Financial Officer | Award | 815K | |
| 2026-06-02 | Myers Behnam Director | Award | 238K | |
| 2026-06-02 | Lerman Michael Stuart Director | Award | 238K | |
| 2026-06-02 | Holman Jeffrey Elliot Chief Executive Officer | Award | 1.29M | |
| 2026-06-02 | Bodzin Gary Director | Award | 238K | |
| 2026-05-25 | Santi Christopher President | Award | 73.6K | |
| 2026-05-25 | Ollet John Chief Financial Officer | Award | 73.6K |
1195 tracked peers · median